Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002857409 | SCV003226172 | pathogenic | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile340Hisfs*13) in the MSH3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MSH3 are known to be pathogenic (PMID: 27476653, 37402566). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MSH3-related conditions. ClinVar contains an entry for this variant (Variation ID: 2020610). For these reasons, this variant has been classified as Pathogenic. |
Myriad Genetics, |
RCV003458883 | SCV004189191 | pathogenic | Familial adenomatous polyposis 4 | 2023-08-29 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |
Baylor Genetics | RCV003464616 | SCV004197545 | likely pathogenic | Endometrial carcinoma | 2021-09-06 | criteria provided, single submitter | clinical testing |